1-(2,6-Dimethylpyridin-3-yl)piperazine → HCID 71252314, compound
Reaction equation
[O:1]=[S:2]1(=[O:20])[CH2:6][CH2:5][CH2:4][N:3]1[C:7]1[CH:15]=[CH:14][C:10]([C:11]([OH:13])=O)=[C:9]([S:16]([CH3:19])(=[O:18])=[O:17])[CH:8]=1.[CH3:21][C:22]1[C:27]([N:28]2[CH2:33][CH2:32][NH:31][CH2:30][CH2:29]2)=[CH:26][CH:25]=[C:24]([CH3:34])[N:23]=1>>[CH3:21][C:22]1[C:27]([N:28]2[CH2:33][CH2:32][N:31]([C:11]([C:10]3[CH:14]=[CH:15][C:7]([N:3]4[CH2:4][CH2:5][CH2:6][S:2]4(=[O:1])=[O:20])=[CH:8][C:9]=3[S:16]([CH3:19])(=[O:18])=[O:17])=[O:13])[CH2:30][CH2:29]2)=[CH:26][CH:25]=[C:24]([CH3:34])[N:23]=1Participants
3
Procedure
Using 4-(1,1-dioxo-1λ6-isothiazolidin-2-yl)-2-methanesulfonylbenzoic acid (189 mg) described in Preparation Example 22 and 1-(2,6-dimethylpyridin-3-yl)piperazine (113 mg) described in Preparation Example 94 and by the reaction and treatment in the same manner as in Example 87, the title compound (102 mg) was obtained.
Workup
- customdescribed in Preparation Example 94 and by the reaction and treatment in the same manner as in Example 87
Sources & evidence
- ORD record
- ord-9135a7c6aa1247b2b50c4e9a5c1b255b
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…